BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 30136753)

  • 21. Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers.
    Mitchell PD; Das JP; Murphy DJ; Keane MP; Donnelly SC; Dodd JD; Butler MW
    Respir Care; 2015 Feb; 60(2):259-68. PubMed ID: 25389350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visually stratified CT honeycombing as a survival predictor in combined pulmonary fibrosis and emphysema.
    Kim YS; Jin GY; Chae KJ; Han YM; Chon SB; Lee YS; Kwon KS; Choi HM
    Br J Radiol; 2015; 88(1055):20150545. PubMed ID: 26388110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial automated quantitative CT analysis in idiopathic pulmonary fibrosis: functional correlations and comparison with changes in visual CT scores.
    Jacob J; Bartholmai BJ; Rajagopalan S; Kokosi M; Egashira R; Brun AL; Nair A; Walsh SLF; Karwoski R; Wells AU
    Eur Radiol; 2018 Mar; 28(3):1318-1327. PubMed ID: 28963678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema.
    Yamamoto Y; Hirata H; Shiroyama T; Kuge T; Matsumoto K; Yoneda M; Yamamoto M; Naito Y; Suga Y; Fukushima K; Miyake K; Koyama S; Iwahori K; Nagatomo I; Takeda Y; Kumanogoh A
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1495-1506. PubMed ID: 35801120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
    Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
    Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of emphysema in pulmonary fibrosis.
    Cottin V
    Eur Respir Rev; 2013 Jun; 22(128):153-7. PubMed ID: 23728869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis.
    Mura M; Zompatori M; Pacilli AM; Fasano L; Schiavina M; Fabbri M
    Respir Care; 2006 Mar; 51(3):257-65. PubMed ID: 16533415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.
    Sato S; Koike T; Hashimoto T; Ishikawa H; Okada A; Watanabe T; Tsuchida M
    Ann Thorac Cardiovasc Surg; 2016 Aug; 22(4):216-23. PubMed ID: 27052999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Texture-Based Automated Quantitative Assessment of Regional Patterns on Initial CT in Patients With Idiopathic Pulmonary Fibrosis: Relationship to Decline in Forced Vital Capacity.
    Park HJ; Lee SM; Song JW; Lee SM; Oh SY; Kim N; Seo JB
    AJR Am J Roentgenol; 2016 Nov; 207(5):976-983. PubMed ID: 27533069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting clinical outcome with phenotypic clusters using quantitative CT fibrosis and emphysema features in patients with idiopathic pulmonary fibrosis.
    Bak SH; Park HY; Nam JH; Lee HY; Lee JH; Sohn I; Chung MP
    PLoS One; 2019; 14(4):e0215303. PubMed ID: 30998772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
    Aono Y; Nakamura Y; Kono M; Nakamura H; Yokomura K; Imokawa S; Toyoshima M; Yasui H; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620953783. PubMed ID: 32928050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
    Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
    BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study.
    Nathan SD; Cottin V; Behr J; Hoeper MM; Martinez FJ; Corte TJ; Keogh AM; Leuchte H; Mogulkoc N; Ulrich S; Wuyts WA; Yao Z; Ley-Zaporozhan J; Müller-Lisse UG; Scholle FD; Brüggenwerth G; Busse D; Nikkho S; Wells AU
    J Heart Lung Transplant; 2021 Jun; 40(6):494-503. PubMed ID: 33744088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis.
    Lee H; Kim SY; Park YS; Choi SM; Lee JH; Park J
    Sci Rep; 2024 Apr; 14(1):8857. PubMed ID: 38632477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis.
    Kurashima K; Takayanagi N; Tsuchiya N; Kanauchi T; Ueda M; Hoshi T; Miyahara Y; Sugita Y
    Respirology; 2010 Jul; 15(5):843-8. PubMed ID: 20546187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial decline in lung volume parameters on computed tomography (CT) predicts outcome in idiopathic pulmonary fibrosis (IPF).
    Robbie H; Wells AU; Fang C; Jacob J; Walsh SLF; Nair A; Camoras R; Desai SR; Devaraj A
    Eur Radiol; 2022 Apr; 32(4):2650-2660. PubMed ID: 34716781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Preoperative Composite Physiologic Index May Predict Mortality in Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema.
    Ueno F; Kitaguchi Y; Shiina T; Asaka S; Miura K; Yasuo M; Wada Y; Yoshizawa A; Hanaoka M
    Respiration; 2017; 94(2):198-206. PubMed ID: 28637046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial changes and prognostic implications of CT findings in combined pulmonary fibrosis and emphysema: comparison with fibrotic idiopathic interstitial pneumonias alone.
    Lee G; Kim KU; Lee JW; Suh YJ; Jeong YJ
    Acta Radiol; 2017 May; 58(5):550-557. PubMed ID: 27565631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Significance of Red Cell Distribution Width in Idiopathic Pulmonary Fibrosis and Combined Pulmonary Fibrosis Emphysema.
    Gürün Kaya A; Özyürek BA; Şahin Özdemirel T; Öz M; Erdoğan Y
    Med Princ Pract; 2021; 30(2):154-159. PubMed ID: 32841950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.